M Shimizu

Relationships Between Plasma Concentrations of Diphenylhydantoin, Phenobarbital, Carbamazepine, and 3‐Sulfamoylmethyl‐1,2‐Benzisoxazole (AD‐810), a New Anticonvulsant Agent, and Their Anticonvulsant or Neurotoxic Effects in Experimental Animals

Yuichi Masuda, Yuzo Utsui, Yuko Shiraishi et al. · Epilepsia · 1979 · 114 citations

Medicine, Pharmacokinetics, Pharmacology +13

New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity

Jun‐ichi Yamagishi, Yasuji Furutani, Satoru Inoue et al. · Journal of Bacteriology · 1981 · 82 citations · Full text

Life Sciences, Genetics, Microbiology +17

In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid

Shinichi Nakamura, Akira Minami, Hiromi Katae et al. · Antimicrobial Agents and Chemotherapy · 1983 · 75 citations

Medicine, Microbiology, Pharmacology +13

3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Pharmacological profile.

Yuichi Masuda, Tadahiko Karasawa, Yuko Shiraishi et al. · PubMed · 1980 · 73 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Pharmacokinetics of a novel quinolone, AT-4140, in animals

Shinichi Nakamura, Nobuyuki Kurobe, Tomio Ohue et al. · Antimicrobial Agents and Chemotherapy · 1990 · 67 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14